Silco Pharmaceuticals Limited (DSE: SILCOPHL)
Bangladesh
· Delayed Price · Currency is BDT
16.70
+0.10 (0.60%)
At close: Dec 19, 2024
Silco Pharmaceuticals Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
Cash & Equivalents | 28.78 | 30.76 | 26.72 | 53.03 | 101.97 | 151.72 | Upgrade
|
Short-Term Investments | - | 18.97 | 37.91 | 19.41 | 155.95 | 150 | Upgrade
|
Cash & Short-Term Investments | 28.78 | 49.73 | 64.63 | 72.44 | 257.92 | 301.72 | Upgrade
|
Cash Growth | -42.13% | -23.04% | -10.79% | -71.91% | -14.52% | 1826.39% | Upgrade
|
Receivables | 439.5 | 377.51 | 389.24 | 390.53 | 484.99 | 489.99 | Upgrade
|
Inventory | 442.61 | 444.14 | 457.84 | 449.45 | 454.71 | 426.03 | Upgrade
|
Prepaid Expenses | - | - | 0.21 | 0.21 | 0.21 | 0.21 | Upgrade
|
Other Current Assets | 162.26 | 133.55 | 136.83 | 139.59 | 126.93 | 107.79 | Upgrade
|
Total Current Assets | 1,073 | 1,005 | 1,049 | 1,052 | 1,325 | 1,326 | Upgrade
|
Property, Plant & Equipment | 1,769 | 1,762 | 1,671 | 1,643 | 1,334 | 1,243 | Upgrade
|
Other Long-Term Assets | - | -0 | -0 | 0 | 0 | 0 | Upgrade
|
Total Assets | 2,843 | 2,767 | 2,720 | 2,696 | 2,659 | 2,568 | Upgrade
|
Accounts Payable | 9.5 | 9.75 | 12.33 | 16.15 | 16.58 | 15.72 | Upgrade
|
Accrued Expenses | 7.72 | 9.67 | 16.93 | 21.21 | 14.87 | 15.72 | Upgrade
|
Current Portion of Leases | 3.14 | - | 4.11 | 3.77 | - | - | Upgrade
|
Current Income Taxes Payable | 290.13 | 273.7 | 255.21 | 240.41 | 223.62 | 200.75 | Upgrade
|
Other Current Liabilities | 2.32 | 2.64 | 2.33 | 1.42 | 4.79 | 6.44 | Upgrade
|
Total Current Liabilities | 312.82 | 295.76 | 290.91 | 282.96 | 259.86 | 238.63 | Upgrade
|
Long-Term Leases | 5.32 | - | - | 4.11 | - | - | Upgrade
|
Long-Term Deferred Tax Liabilities | 153.76 | 151.73 | 150.21 | 140.5 | 152.3 | 147.45 | Upgrade
|
Other Long-Term Liabilities | -0 | -0 | - | 0 | -0 | - | Upgrade
|
Total Liabilities | 471.89 | 447.5 | 441.11 | 427.57 | 412.17 | 386.08 | Upgrade
|
Common Stock | 1,038 | 1,038 | 1,038 | 1,038 | 1,038 | 943.7 | Upgrade
|
Retained Earnings | 1,333 | 1,289 | 1,251 | 1,230 | 1,208 | 1,238 | Upgrade
|
Comprehensive Income & Other | - | -6.92 | -10.69 | -0.37 | - | - | Upgrade
|
Shareholders' Equity | 2,371 | 2,320 | 2,279 | 2,268 | 2,246 | 2,182 | Upgrade
|
Total Liabilities & Equity | 2,843 | 2,767 | 2,720 | 2,696 | 2,659 | 2,568 | Upgrade
|
Total Debt | 8.46 | - | 4.11 | 7.89 | - | - | Upgrade
|
Net Cash (Debt) | 20.32 | 49.73 | 60.51 | 64.56 | 257.92 | 301.72 | Upgrade
|
Net Cash Growth | -59.14% | -17.81% | -6.26% | -74.97% | -14.52% | 1826.39% | Upgrade
|
Net Cash Per Share | 0.20 | 0.48 | 0.58 | 0.62 | 2.48 | 3.75 | Upgrade
|
Filing Date Shares Outstanding | 100.89 | 103.81 | 103.81 | 103.81 | 103.81 | 103.81 | Upgrade
|
Total Common Shares Outstanding | 100.89 | 103.81 | 103.81 | 103.81 | 103.81 | 103.81 | Upgrade
|
Working Capital | 760.33 | 709.17 | 757.83 | 769.27 | 1,065 | 1,087 | Upgrade
|
Book Value Per Share | 23.50 | 22.35 | 21.95 | 21.85 | 21.64 | 21.02 | Upgrade
|
Tangible Book Value | 2,371 | 2,320 | 2,279 | 2,268 | 2,246 | 2,182 | Upgrade
|
Tangible Book Value Per Share | 23.50 | 22.35 | 21.95 | 21.85 | 21.64 | 21.02 | Upgrade
|
Land | - | 74.85 | 74.85 | 74.85 | 74.85 | 74.85 | Upgrade
|
Buildings | - | 1,004 | 880.25 | 700.05 | 477.1 | 472.28 | Upgrade
|
Machinery | - | 1,524 | 1,443 | 1,320 | 1,317 | 1,276 | Upgrade
|
Construction In Progress | - | 174.96 | 197.38 | 394.59 | 243.52 | 119.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.